Zhejiang Cheng Yi Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 459.49 million compared to CNY 476.22 million a year ago. Revenue was CNY 459.49 million compared to CNY 476.22 million a year ago.

Net income was CNY 113.95 million compared to CNY 102.53 million a year ago. Basic earnings per share from continuing operations was CNY 0.35 compared to CNY 0.31 a year ago. Diluted earnings per share from continuing operations was CNY 0.35 compared to CNY 0.31 a year ago.